Yale Babesia Article

Thanks for sharing, caught this study the other week. The one good thing about it is that it corroborates the patient experience, and hopefully will get more researchers looking at better therapeutics for this organism. So while it might be a bit depressing, I consider this study a step in the right direction.

Charlie:

"They also tested four current drugs that are used to treat the disease and found that the parasite has low susceptibility to these therapies."

Do you know what the 4 current drugs are? (I'm assuming Mepron and Malarone are two of them?)


I guess this is why Dr. J. puts so much emphasis on Babesia....

Lovely.

Girlie, the four drugs are atovaquone, azithromycin, clindamycin and quinine. I got to the abstract but not the full article yet.

Thanks for sharing.

Dahlias said...
Lovely.

Girlie, the four drugs are atovaquone, azithromycin, clindamycin and quinine. I got to the abstract but not the full article yet.

Thanks for sharing.

Yes thanks Dahlias, was interested about that too.

Now remember, these are drugs being used are probably being used separately "I think." I'm sure some of them are more effective once combined, just like on borrelia. I HOPE! lol

sierraDon said...
Its strain specific, duncani isnt responsive to the four known drugs. The other strains are responsive.

I'm sure the other strains are just as resilient! It's probably good to rotate your parasite drugs or pulse them, just like they do with Artemisia.

And yes, those LLMDs that prescribe mepron for 4 months, just hoping for the best, I think we need to get past that ideology.

sierraDon said...

Its good more if these studies are coming to the forefront, but i dont feel this isnt anything that isnt already known, similar to the lyme biofilm and persister challenges, and viralence with bartonella. Just more evidence, when will idsa or cdc acknowledge this, curious to see what idsa revised guidlines will be, those should be out soon. And now that cdc announced the growth of these pathogens, whats next with them

Depends on the LLMD, their knowledge, and how set in they're ways with there protocols they are. I just called up supposedly the top LLMD in my state, asked if he has changed his protocols yet to address biofilms and persister cells. I got some smart ass answer that they use protocols to work specifically with everyone's body etc... I exclaimed to them how I handed the Doctor the paper work on the John Hopkins study four years ago, why haven't they changed?

I'm very very very very worried for the future! Majority of Lyme Literate Doctors aren't adapting like Dr. J and Dr. H. Some LLMDs are just as egotistical as Doctors in the traditional medical establishment, similar to being set in their ways. I'm sure some of it has to do with losing there license still in some states where they aren't protected.

This will just be more proof for the tickborne working group, those that are suing the CDC, and Lyme patients trying to get disability. What is known and what is in writing through studies is so much different. Remember the battle isn't just treatment with this disease...

https://www.courthousenews.com/insurers-accused-conspiring-deny-lyme-disease-coverage/
https://www.ctpost.com/local/article/milford-scientist-suing-cdc-over-lyme-test-13409351.php

Post Edited (Charlie55) : 12/1/2018 2:08:41 PM (GMT-7)

2019 i think will be a landmark year with TBD.

a lot of things could happen with the various court cases, IDSA guidelines release (LOL), TBD working group congress, other ventures like Dr SP/Spector's inniative, plus all the research in queue in the various medical research laboratories. i am sure there are many other things goin on.

my hope is there is some alignment with policy, IDSA's grip just continues to loosen and fade.

I didn't have a second anti-malarial pharma combined with the Mepron...just abx - ie mino/ceftin/bactrim (until I discontinued it because of rashes)....I did have Artemisinin though.


I'm now taking clindamycin for one of my weeks each cycle.